Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators | Patent Publication Number 20210017168
US 20210017168 A1Patent NumberUS 11618750 B2
Application Number16899823
Filled DateJun 12, 2020
Priority DateJun 14, 2019
Publication DateJan 21, 2021
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsCurt Dvorak
Christa Chrovian
Akinola SOYODE-JOHNSON
Michael A. LETAVIC
Akinola Soyode-Johnson
Christa CHROVIAN
Michael A. Letavic
Christine GELIN
Andrew Samant
Curt DVORAK
Afton HISCOX
Afton Hiscox
Andrew SAMANT
Brice Stenne
Christine Gelin
Brice STENNE
Christa Chrovian
Akinola SOYODE-JOHNSON
Michael A. LETAVIC
Akinola Soyode-Johnson
Christa CHROVIAN
Michael A. Letavic
Christine GELIN
Andrew Samant
Curt DVORAK
Afton HISCOX
Afton Hiscox
Andrew SAMANT
Brice Stenne
Christine Gelin
Brice STENNE
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.